Omezyl (Omeprazole)

Omeprazole, the active ingredient in Omezyl, is a proton pump inhibitor presented as a 20 mg tablet for oral use. It reduces stomach acid production and is used to manage acid‑related gastrointestinal conditions in adults and children. GNH USA supplies Omezyl as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Omezyl as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omezyl is a proton pump inhibitor that acts on the gastric acid secretion pathway to treat several acid‑related disorders.

- Gastro‑esophageal reflux disease (GERD): provides symptomatic relief and promotes healing of esophageal erosion. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with the condition. - Helicobacter pylori eradication regimens (as part of combination therapy): enhances eradication success by suppressing acid. - NSA‑related ulcer prophylaxis: lowers risk of ulcer development in patients requiring chronic NSAID therapy.

Adverse reactions to Omezyl may vary in frequency and severity.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually self‑limiting. - Abdominal pain or discomfort. - Nausea or vomiting. - Flatulence or bloating. - Constipation.

Serious or Rare Side Effects: - Acute interstitial nephritis. - Severe hypersensitivity reactions (e.g., Stevens‑Johnson syndrome). - Clostridioides difficile‑associated colitis. - Low magnesium levels (hypomagnesemia) with prolonged use. - Fracture risk increase with long‑term therapy. - Vitamin B12 deficiency with extended treatment.

When prescribing Omezyl, clinicians should consider several safety aspects.

- Assess renal function: dose adjustment may be needed in severe impairment. - Review concomitant medications: potential for drug‑drug interactions. - Monitor long‑term users: watch for magnesium deficiency and bone health. - Pregnancy and lactation: use only if clearly needed after risk‑benefit evaluation. - Elderly patients: start at the lowest effective dose and monitor closely. - Store at below 25°C: keep in the original container, protect from moisture and light.

Omeprazole can affect the pharmacokinetics of several co‑administered drugs.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, may increase cardiovascular risk. - Atazanavir and other protease inhibitors: decreased antiviral efficacy. - Methotrexate (high dose): increased toxicity risk.

Moderate Interactions (Monitor Closely): - Warfarin: potential alteration of INR values. - Digoxin: possible increase in serum concentrations. - Phenytoin: reduced serum levels, may diminish seizure control. - Iron supplements: decreased absorption, separate dosing by at least 2 hours.